In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential merger. Though some doubt the feasibility of such a deal, this would be the biggest healthcare merger on record.

To maintain successful business partnerships, law firms need to regularly assess new ways to benefit their IP clients. By putting in the effort to expand client relationships, firms can better demonstrate the value of their ongoing service.

As legal tech revolutionizes the industry, offering new avenues for speed, accuracy, and quality assurance in legal work, often, one roadblock remains - the budget-minded CFO.

Now is not the time to be idle. There are plenty of steps in-house IP departments can take now to ensure team productivity, strategic budgeting, and a strong patent portfolio.

With budgets tightening and department priorities shifting, now is the time for companies to evaluate outside legal counsel.

Following industry news these days, it’s hard to avoid theories that the economic instability created by COVID-19 will be the death of patent prosecution.

As businesses feel the lingering stress from the COVID-19 pandemic, some are considering bringing patent prosecution in-house in order to cut costs. With clients continuing to mind their budgets, how can firms demonstrate the cost savings and ROI they bring to the table?

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.

Big business is all about data. We see it in almost every industry, from healthcare to financial services to aviation and beyond. But the legal industry has been slow to adapt.

Executives at T-Mobile may be weighing a potential merger with Comcast, the largest U.S. cable provider.